Bir sonraki

Otomatik oynatma

A Q&A On Comprehensive Genomic Profiling in rare cancers and cancer of unknown primary.

4 Görünümler • 07/10/23
Pay
gömmek
administrator
administrator
Aboneler
0

A Q&A with TargetCancer Foundation on Comprehensive Genomic Profiling and its relevance in rare cancers and cancer of unknown primary, as well as its incorporation in the TRACK Study.

Featuring:
Jim Palma, Executive Director, TargetCancer Foundation
Dr. Prasanth Reddy, VP of Medical Affairs, Foundation Medicine

Daha fazla göster
0 Yorumlar sort Göre sırala
Facebook Yorumları

Bir sonraki

Otomatik oynatma